1-237792141-C-T
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP2BP4_ModerateBS2
The NM_001035.3(RYR2):c.13600C>T(p.Pro4534Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000158 in 1,454,876 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001035.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RYR2 | NM_001035.3 | c.13600C>T | p.Pro4534Ser | missense_variant | 94/105 | ENST00000366574.7 | NP_001026.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RYR2 | ENST00000366574.7 | c.13600C>T | p.Pro4534Ser | missense_variant | 94/105 | 1 | NM_001035.3 | ENSP00000355533.2 | ||
RYR2 | ENST00000609119.2 | n.*4692C>T | non_coding_transcript_exon_variant | 93/104 | 5 | ENSP00000499659.2 | ||||
RYR2 | ENST00000609119.2 | n.*4692C>T | 3_prime_UTR_variant | 93/104 | 5 | ENSP00000499659.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000464 AC: 11AN: 237172Hom.: 0 AF XY: 0.0000312 AC XY: 4AN XY: 128226
GnomAD4 exome AF: 0.0000158 AC: 23AN: 1454876Hom.: 0 Cov.: 31 AF XY: 0.0000180 AC XY: 13AN XY: 722878
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2023 | - - |
Uncertain significance, criteria provided, single submitter | research | Biesecker Lab/Clinical Genomics Section, National Institutes of Health | Jun 24, 2013 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 30, 2015 | p.Pro4534Ser (CCC>TCC): c.13600 C>T in exon 94 of the RYR2 gene (NM_001035.2). The Pro4534Ser variant in the RYR2 gene has not been reported as a disease-causing mutation or as a benign polymorphism to our knowledge. Pro4534Ser was not observed in approximately 6000 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Pro4534Ser results in a non-conservative amino acid substitution of a non-polar Proline with a polar Serine at a position that is not well conserved across species, but is located in one of three mutation hot spot regions in the RYR2 gene (Medeiros- Domingo A et al., 2009). Nevertheless, in-silico analysis programs predict Pro4534Ser is benign to the protein structure/function. We cannot definitively determine if Pro4534Ser is a disease-causing mutation or a rare benign variant. The variant is found in POSTMORTEM panel(s). - |
not specified Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Stanford Center for Inherited Cardiovascular Disease, Stanford University | Jun 01, 2015 | Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease. p.Pro4534Ser (c.13600C>T) in the RYR2 gene (NM_001035) Given the lack of case data and lack of ancestry-matched controls, we consider this variant a variant of uncertain significance. I could find no report of the variant in association with disease. It is not listed in ClinVar (as of July 8th, 2014). Per Ng et al (2013) it is not listed in HGMD or any LSDB they checked. In silico analysis with PolyPhen-2 predicts the variant to be benign. The proline at codon 4534 is conserved across species. In total the variant has been seen in 1 of 7009 individuals from publicly available population datasets. There is no variation at codon 4534 listed in the NHLBI Exome Sequencing Project dataset, which currently includes variant calls on ~6500 Caucasian and African American individuals (as of July 8th, 2014). The variant was seen in 1 of 509 individuals in the ClinSeq project (Ng et al 2013), a sample not selected for arrhythmia or family history of sudden death (3.7% were Hispanic). Note that this dataset does not match the patient's ancestry (Hispanic). The variant is listed in dbSNP with the only submission being the ClinSeq data (rs199624074). - |
Catecholaminergic polymorphic ventricular tachycardia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Nov 30, 2023 | This missense variant replaces proline with serine at codon 4534 of the RYR2 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual afflicted with unspecified cardiomyopathy (PMID: 30847666). This variant has been identified in 11/237172 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Dec 02, 2022 | This missense variant replaces proline with serine at codon 4534 of the RYR2 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual afflicted with unspecified cardiomyopathy (PMID: 30847666). This variant has been identified in 11/237172 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Catecholaminergic polymorphic ventricular tachycardia 1 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 29, 2023 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 09, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at